SYNAP leverages a scientifically validated amino acid formula—derived from KB220Z neuroadaptagen—designed to regulate core neurotransmitters like dopamine, serotonin, GABA, and endorphins. This carefully balanced blend promotes optimal reward signaling pathways in the brain’s mesolimbic system, helping maintain satisfaction, focus, and emotional stability.

At the heart of the brain’s reward system, dopamine serves as a critical signal for pleasure, motivation, and calm. SYNAP’s formulation supports this system by rebalancing neurotransmitter interactions across the reward cascade—reducing cravings, enhancing mood, and encouraging sustainable mental wellness.

The Research Behind SYNAP

SYNAP delivers a scientifically backed “jumpstart” to recovery—quickly reducing cravings and withdrawal symptoms. This enables individuals to engage more deeply in therapy and benefit more fully from ongoing treatment modalities. Over time, SYNAP strengthens the quality of sobriety and lowers relapse likelihood through sustained neurochemical balance.